FR2407719A1 - Composition antiacide pour le traitement de l'hyperacidite gastrique comprenant des microcristaux de carbonate de calcium et d'hydroxy-carbonate de magnesium dans une matrice d'hydroxyde d'aluminium amorphe, et sa preparation - Google Patents
Composition antiacide pour le traitement de l'hyperacidite gastrique comprenant des microcristaux de carbonate de calcium et d'hydroxy-carbonate de magnesium dans une matrice d'hydroxyde d'aluminium amorphe, et sa preparationInfo
- Publication number
- FR2407719A1 FR2407719A1 FR7831323A FR7831323A FR2407719A1 FR 2407719 A1 FR2407719 A1 FR 2407719A1 FR 7831323 A FR7831323 A FR 7831323A FR 7831323 A FR7831323 A FR 7831323A FR 2407719 A1 FR2407719 A1 FR 2407719A1
- Authority
- FR
- France
- Prior art keywords
- carbonate
- amorphic
- matrix
- aluminum hydroxide
- antiacidal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title abstract 4
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 title abstract 2
- 229910000019 calcium carbonate Inorganic materials 0.000 title abstract 2
- OUHCLAKJJGMPSW-UHFFFAOYSA-L magnesium;hydrogen carbonate;hydroxide Chemical compound O.[Mg+2].[O-]C([O-])=O OUHCLAKJJGMPSW-UHFFFAOYSA-L 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 title abstract 2
- 206010020601 Hyperchlorhydria Diseases 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- 239000013081 microcrystal Substances 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 230000001458 anti-acid effect Effects 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'INVENTION SE RAPPORTE AUX MEDICAMENTS. ELLE CONCERNE UNE COMPOSITION ANTI-ACIDE CARACTERISEE EN CE QU'ELLE COMPREND DES STRUCTURES MICROCRISTALLINES DE CARBONATE DE CALCIUM ET D'HYDROXY-CARBONATE DE MAGNESIUM DISPERSEES DANS UNE MATRICE D'HYDROXYDE D'ALUMINIUM AMORPHE, ET CONTIENT, EN POIDS, 25 A 30 D'ALUMINIUM CALCULE EN ALO, 1,0 A 1,8 DE CALCIUM CALCULE EN CAO ET 13 A 19 DE MAGNESIUM CALCULE EN MGO. UTILISATION DANS L'INDUSTRIE PHARMACEUTIQUE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772749506 DE2749506A1 (de) | 1977-11-04 | 1977-11-04 | Mittel gegen magensaeure, verfahren zu seiner herstellung und dieses mittel enthaltende pharmazeutische zubereitung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2407719A1 true FR2407719A1 (fr) | 1979-06-01 |
| FR2407719B1 FR2407719B1 (fr) | 1981-12-04 |
Family
ID=6023066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7831323A Granted FR2407719A1 (fr) | 1977-11-04 | 1978-11-06 | Composition antiacide pour le traitement de l'hyperacidite gastrique comprenant des microcristaux de carbonate de calcium et d'hydroxy-carbonate de magnesium dans une matrice d'hydroxyde d'aluminium amorphe, et sa preparation |
Country Status (10)
| Country | Link |
|---|---|
| AR (1) | AR216706A1 (fr) |
| AT (1) | AT365928B (fr) |
| BE (1) | BE871767A (fr) |
| CA (1) | CA1111767A (fr) |
| CH (1) | CH642545A5 (fr) |
| DE (1) | DE2749506A1 (fr) |
| FR (1) | FR2407719A1 (fr) |
| GB (1) | GB2008942B (fr) |
| IL (1) | IL55793A0 (fr) |
| IT (1) | IT1106221B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2262287A (en) * | 1991-12-11 | 1993-06-16 | Evode Ltd | Flame-retardant filler for thermoplastic compositions |
| US8257750B2 (en) * | 1999-04-30 | 2012-09-04 | Kibow Biotech, Inc. | Calcium carbonate compositions for preventing or treating hyperphosphatemia |
| WO2018229789A1 (fr) | 2017-06-12 | 2018-12-20 | Council Of Scientific & Industrial Research | Composé antiacide de base inorganique présentant des propriétés améliorées et nouvelles |
-
1977
- 1977-11-04 DE DE19772749506 patent/DE2749506A1/de not_active Ceased
-
1978
- 1978-10-24 IT IT51610/78A patent/IT1106221B/it active
- 1978-10-25 IL IL7855793A patent/IL55793A0/xx not_active IP Right Cessation
- 1978-10-31 AT AT0777578A patent/AT365928B/de not_active IP Right Cessation
- 1978-11-02 GB GB7842940A patent/GB2008942B/en not_active Expired
- 1978-11-03 AR AR274343A patent/AR216706A1/es active
- 1978-11-03 CA CA315,797A patent/CA1111767A/fr not_active Expired
- 1978-11-03 BE BE191540A patent/BE871767A/fr not_active IP Right Cessation
- 1978-11-03 CH CH1134778A patent/CH642545A5/de not_active IP Right Cessation
- 1978-11-06 FR FR7831323A patent/FR2407719A1/fr active Granted
Non-Patent Citations (1)
| Title |
|---|
| EXBK/76 * |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2749506A1 (de) | 1979-05-10 |
| GB2008942B (en) | 1982-05-06 |
| BE871767A (fr) | 1979-03-01 |
| IT7851610A0 (it) | 1978-10-24 |
| FR2407719B1 (fr) | 1981-12-04 |
| AR216706A1 (es) | 1980-01-15 |
| AT365928B (de) | 1982-02-25 |
| IT1106221B (it) | 1985-11-11 |
| GB2008942A (en) | 1979-06-13 |
| ATA777578A (de) | 1981-07-15 |
| IL55793A0 (en) | 1978-12-17 |
| CH642545A5 (de) | 1984-04-30 |
| CA1111767A (fr) | 1981-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY7800034A (en) | Direct compression tabletting composition and tablets produced therefrom | |
| FR2503562B1 (fr) | Conditionnement pharmaceutique pour le traitement des symptomes de menopause | |
| FR2333515A1 (fr) | Compositions pharmaceutiques pour le traitement des troubles du metabolisme du calcium | |
| GB1380171A (en) | Medicinal tablets | |
| FR2407719A1 (fr) | Composition antiacide pour le traitement de l'hyperacidite gastrique comprenant des microcristaux de carbonate de calcium et d'hydroxy-carbonate de magnesium dans une matrice d'hydroxyde d'aluminium amorphe, et sa preparation | |
| EP0011490A3 (en) | Analgesic tablet and process for its preparation | |
| NZ295365A (en) | Competitive progesterone antagonists for regulating female fertility as required | |
| ES8203099A1 (es) | Un metodo de almacenar calor. | |
| SE7606287L (sv) | Eldfast komposition | |
| BE831234A (fr) | Procede de dosage radio-immunologique pour la mise en evidence des anticorps de neisseria gonorrheae | |
| BE884756A (fr) | Composition dermatologique pour le traitement des maladies de la peau, accompagnees d'une proliferation cellulaire, telles que le psoriasis | |
| GB521215A (en) | Improvements in or relating to compositions for heating by exothermic reactions | |
| GB1502873A (en) | Pharmaceutical compositions with ulcer healing activity | |
| FR2303082A1 (fr) | Procede pour la preparation d'une matrice de micro-organismes | |
| CA970136A (en) | Procede d'epuration des gaz industriels contenant des dioxydes de soufre | |
| FR2499572B1 (fr) | Le 3',4',5'-trimethoxybenzoate de 17,18-deshydroapovincaminol et ses sels formes par addition avec des acides, leurs utilisations therapeutiques dans le traitement de maladies associees a une proliferation cellulaire, procedes pour leur preparation et produits intermediaires de leur preparation | |
| YU72375A (en) | Process for obtaining magnesium oxide from ores containing magnesium compounds as main ingredient | |
| IT1157271B (it) | Composizione farmaceutica per combattere l'aggregazione delle piastrine | |
| JPS5432342A (en) | Liquid crystal display body | |
| CA922848A (en) | Allytin compounds as modifiers for haloaryllithium initiated polymerizations of isoprene or butadiene | |
| SU394046A1 (ru) | Таблетированный препарат для лечения и профилактики йодной недостаточности | |
| Teoreanu et al. | Interaction mechanism of 2 CaO multiplied by Fe sub 2 O sub 3 and 4 CaO multiplied by Al sub 2 O sub 3 multiplied by Fe sub 2 O sub 3 with water, at various pressures and temperatures | |
| CA2122478A1 (fr) | Forme de dose unitaire du subsalicylate de bismuth | |
| JPS5221326A (en) | Plant disease controlling agent | |
| NL7416691A (nl) | Werkwijze voor de bereiding van 17(alpha)-acyloxy-21- oxypregnanen, alsmede farmaceutische pre- en die deze verbindingen als actieve com- ten omvatten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TP | Transmission of property | ||
| ST | Notification of lapse |